CTOs on the Move

InVivo Therapeutics

www.invivotherapeutics.com

 
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children`s Hospital and who now is affiliated with Massachusetts General Hospital. The publicly traded company is headquartered in Cambridge, MA.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

InVivo Therapeutics raised $41M on 03/14/2016

Similar Companies

Allied Healthcare Systems

Allied Healthcare Systems is a Jamestown, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ASA Health Inc

ASA Health Inc is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Care Solutions Inc

Health Care Solutions Inc is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aerohive

Aerohive delivers cloud networking that transforms the Connected Experience. Our simple, secure, and scalable mobility solutions build on cloud networking, great Wi-Fi, and applications and insights, to create the Connected Experience Platform, enabling organizations to leverage the power of mobility to increase productivity, engage customers, and grow their business. At Aerohive, we believe that every access point is a starting point.

iCAD

With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world`s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world`s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide.